News & Videos - PEDIATRIX MEDICAL GROUP INC.

Miller Children's & Women's Announces New Miller Children's & Women's Neonatal Network in Partnership with Pediatrix Medical Group, Dr. Antoine Soliman Named Regional Medical Director PR Newswire LONG BEACH, Calif., Nov. 16, 2023 November is Prematurity Awareness Month, Announcement Comes in Celebration of World Prematurity Day on Friday, Nov. 17 LONG BEACH, Calif. , Nov. 16, 2023 /PRNewswire/ -- MemorialCare Miller Children's & Women's Hospital Long Beach , along with Pediatrix Medical Group ,...

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.34 per share for the three months ended June 30, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.39. For the 2023 second quarter, Pediatrix reported the following results from continuing operations: Net revenue of $501 million; Income from continuing...

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, August 3, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended June 30, 2023. A detailed press release will be issued the morning of August 3, 2023 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors . ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc....

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today announced that its board of directors has appointed Sylvia Young, a recognized leader in healthcare and long-term healthcare executive, as an independent director, effective May 12, 2023. Ms. Young, a veteran of hospital administration since 1985, most recently served as President and CEO of the HCA Continental Division, a multi-state regional...

Pediatrix Medical Group, Inc. (NYSE: MD) today announced that it will present on Tuesday, May 9, 2023 at 5:00 pm PT to investors attending the 2023 Bank of America Health Care Conference in Las Vegas, Nevada. The presentation will be broadcast through live audio webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors . ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is the nation’s leading provider of physician services. Pediatrix-affiliated...

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.17 per share for the three months ended March 31, 2023. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.23. For the 2023 first quarter, Pediatrix reported the following results from continuing operations: Net revenue of $491 million; Income from continuing...

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, May 2, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2023. A detailed press release will be issued the morning of May 2, 2023 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors . ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD)...

Pediatrix Medical Group, Inc. (NYSE: MD) today announced that its board of directors has elected James D. Swift, M.D., the Company’s chief executive officer, as a director effective March 8, 2023. This appointment fills a seat previously held by Roger J. Medel, M.D. “Jim’s election follows his recent appointment as chief executive officer,” said Mark S. Ordan, executive chair of Pediatrix Medical Group. “On behalf of the Board, I also want to honor Roger, a co-founder of Pediatrix, for...

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, babies and children, will host the top meeting in neonatal medicine Feb. 22-24 in Las Vegas, Nevada. More than 385 physicians, allied health professionals, advanced practitioners/registered nurses, residents/fellows and exhibitors are expected to attend NEO: The Conference for Neonatology, where experts will address many of the most critical and controversial issues that...

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.29 per share for the three months ended December 31, 2022. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.47. For the 2022 fourth quarter, Pediatrix reported the following results from continuing operations: Net revenue of $514 million; Income from continuing...

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Friday, February 17, 2023 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2022. A detailed press release will be issued the morning of February 17, 2023 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors . ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group,...

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, babies and children, today announced that the Company’s board of directors has appointed James D. Swift, M.D., as chief executive officer, to succeed Mark S. Ordan, who has been named executive chair of the Company’s board of directors and has served as chief executive officer since July 2020. Guy P. Sansone, who previously served as chair of the Company’s board of...

Pediatrix® Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, babies and children, today released its inaugural sustainability report which outlines Pediatrix’s approach and business practices related to its Environmental, Social and Governance (ESG) efforts. The report is a milestone in the company’s commitment to transparently providing ESG information to its key stakeholders. “In today’s environment, it is no longer...

Pediatrix Medical Group, Inc. (NYSE: MD) today announced that it will present on Tuesday, November 8, 2022 at 3:15 p.m. PT to investors attending the Credit Suisse 31 st Annual Healthcare Conference in Rancho Palos Verdes, California. The presentation will be broadcast through live audio webcasts. The investor conference call will be webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors . ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is the...

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.35 per share for the three months ended September 30, 2022. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.40. For the 2022 third quarter, Pediatrix reported the following results from continuing operations: Net revenue of $490 million; Income from continuing...

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, November 3, 2022 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2022. A detailed press release will be issued the morning of November 3, 2022 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors . ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group,...

Pediatrix Medical Group, Inc. (NYSE: MD) today provided commentary on the final rule issued on August 19, 2022 by the Departments of the Treasury, Labor, and Health and Human Services related to the No Surprises Act. The final rule states that a qualifying payment amount (QPA), described as a calculation of a median in-network rate, is only one of multiple inputs to be considered by the arbitrators in the independent dispute resolution (IDR) process by which out-of-network providers and insurers...

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, today reported earnings from continuing operations of $0.36 per share for the three months ended June 30, 2022. On a non-GAAP basis, Pediatrix reported Adjusted EPS from continuing operations of $0.47. For the 2022 second quarter, Pediatrix reported the following results from continuing operations: Net revenue of $486 million; Income from continuing...

Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, August 4, 2022 at 9:00 a.m. ET to discuss results from operations for the quarter ended June 30, 2022. A detailed press release will be issued the morning of August 4, 2022 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix’s website, www.pediatrix.com/investors . ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc....

Mednax, Inc. (NYSE: MD) today announced that it will change its corporate name to Pediatrix Medical Group, Inc., effective after the close of the market on July 1, 2022. The Company’s common stock will continue to trade on the New York Stock Exchange under the current ticker symbol “MD.” “We are excited to complete this full return to Pediatrix, a nationally well-known and highly respected name,” said Mark S. Ordan, Mednax’s Chief Executive Officer. “This underscores our position...